Daniel D Burgess's Net Worth
$511 Thousand
Who is Daniel D Burgess?
Daniel D Burgess does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Arbutus Biopharma Corp, Nabriva Therapeutics plc, Cidara Therapeutics, Inc., SANTARUS INC, METABASIS THERAPEUTICS INC, and HOLLIS EDEN PHARMACEUTICALS INC /DE/.
SEC CIK
Daniel D Burgess's CIK is 0001239650
Past Insider Trading and Trends
2013 was Daniel D Burgess's most active year for acquiring shares with 7 total transactions. Daniel D Burgess's most active month to acquire stocks was the month of May. 2013 was Daniel D Burgess's most active year for disposing of shares, totalling 11 transactions. Daniel D Burgess's most active month to dispose stocks was the month of December. 2018 saw Daniel D Burgess paying a total of $99,000.00 for 113,000 shares, this is the most they've acquired in one year. In 2014 Daniel D Burgess cashed out on 378,000 shares for a total of $9,712,840.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nabriva Therapeutics Plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
No matching records found |
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Nabriva Therapeutics plc (NBRVF) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -52.20% | -11.34K |
$0.19 | -$2,155.92 | 10.38K |
Aug 2
| |||
Form 4
| -4.92% | -1.13K |
$1.20 | -$1,350.00 | 21.73K |
Aug 2
| |||
Form 4
| +327.10% | 17.5K |
—
|
—
| 22.85K |
Jul 28
| |||
Form 4
| +48.61% | 17.5K |
—
|
—
| 53.5K |
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
∞
| 36K |
$2.75 | $99,000.00 | 36K |
Jul 31 - Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cidara Therapeutics, Inc. (CDTX) Snapshot price: $13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 3K |
$16.00 | $48,000.00 | 3K |
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SANTARUS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
$12.17 | -$146,726.40 |
0
|
Scheduled
|
Jun 3
| ||
Form 4
|
—
|
0
|
$10.44 | -$119,047.20 |
0
|
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$9.78 | -$123,053.60 |
0
|
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$7.28 | -$97,513.60 |
0
|
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$7.23 | -$96,804.80 |
0
|
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |